U.S. market Closed. Opens in 2 days 6 hours 24 minutes

TECH | Bio-Techne Corporation Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 70.61 - 72.41
52 Week Range 61.16 - 85.57
Beta 1.27
Implied Volatility 31.76%
IV Rank 31.60%
Day's Volume 589,913
Average Volume 929,301
Shares Outstanding 158,892,000
Market Cap 11,325,821,760
Sector Healthcare
Industry Biotechnology
IPO Date 1989-02-09
Valuation
Profitability
Growth
Health
P/E Ratio 75.03
Forward P/E Ratio 42.26
EPS 0.95
1YR Price Target 80.00
Dividend Yield 0.45%
Dividend Per Share 0.32
Dividend ExDate 2023-11-09
Dividend PayDate 2023-11-24
Employees 3,100
Country USA
Website TECH
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
*Chart delayed
Analyzing fundamentals for TECH we got that it has average fundamentals where Valuation is considered to be slightly overvalued, Profitability is poor, Growth is good and Health is strong. For more detailed analysis please see TECH Fundamentals page.

Watching at TECH technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on TECH Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙